About: Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 23 January 2009

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2009 (uk) im April 2009 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 23 January 2009 (en) artículu científicu espublizáu en xineru de 2009 (ast)
publication date	wds:Q58620300-AF7D647D-BCCA-44CD-901C-56D21B1F4ED1
publication date	2009-01-23 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58620300-F024DB47-C1BE-4AC1-ADC0-DE4B44D614A0
language of work or name	English
cites work	wds:Q58620300-115C35C1-B03B-4E17-A63C-D3BE0CA786EF wds:Q58620300-187EA654-4375-4F3F-97E4-E267C4B1CA54 wds:Q58620300-1C416E9F-6641-45C8-B174-A85B9B77BB35 wds:Q58620300-1C827B15-0846-4C54-958B-BA47F1DEA0A8 wds:Q58620300-1F676E5D-14DC-4467-8282-FAD815ABC912 wds:Q58620300-2522547C-87F7-4F14-AB05-B413D1EE7E7D wds:Q58620300-35D402AB-8B91-48F3-83AE-33B4C2AAC73C wds:Q58620300-3742D9DB-5725-42D6-9A7B-1CACE67E7AE5 wds:Q58620300-3786DC7B-C9C7-40BD-8161-9A7213FC95C9 wds:Q58620300-40180D3B-120F-4012-B4AB-C05E97F74C4B wds:Q58620300-55E96A62-FA60-43EB-8102-5C1B8791094D wds:Q58620300-5EFCB016-E87D-4A77-B8DE-F1AEBD9EDB45 wds:Q58620300-7AFED8B1-4A7D-4107-B8C9-56B339429B1B wds:Q58620300-7B923AC8-D891-4130-B290-69A4FAE92AF2 wds:Q58620300-7ECB662A-2843-44AC-9EB1-DE846157F558 wds:Q58620300-80839CAE-DCE6-429A-8C10-8E0E7A1DAE0E wds:Q58620300-80AB6762-F464-4412-9766-CA49F941D0D2 wds:Q58620300-88E46B28-6386-4686-9AC3-404213D069AF wds:Q58620300-8A54B849-45CD-4C05-90CA-8CD3BEF175BB wds:Q58620300-A58C25CE-DD21-4533-B8C7-F317A9754C12 wds:Q58620300-B6874903-1964-4072-9114-C5BD6883B2B3 wds:Q58620300-BEA90A85-EDAE-44C8-BD48-93EFFB3DAB60 wds:Q58620300-C38928A9-349F-471F-AFAB-E2FF5B64AFE5 wds:Q58620300-C72040E7-43DA-4946-8BB1-AF58AC742013 wds:Q58620300-D7F152AB-7A67-4CBB-904D-D6E4683CEE37 wds:Q58620300-EDA43A56-E5B3-4C82-A466-EDA7ED143C2F wds:Q58620300-EE1C49EC-6CC1-49B5-A9F1-18DF4C76FB78 wds:Q58620300-F51903D3-72B7-47B0-A3BE-E347BA45A317 wds:Q58620300-F9B463DE-4BAD-4713-BBC5-172F49875D69 wds:Q58620300-FA3C16F9-6DDE-4B78-8529-F39E7BEDB38C wds:Q58620300-FEC04863-CE29-495F-98BD-E406F196767B
cites work	Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions Models for longitudinal data: a generalized estimating equation approach Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins A Wilcoxon-type test for trend The meaning and use of the area under a receiver operating characteristic (ROC) curve The type I interferon system in systemic lupus erythematosus Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Dysfunctional B cells in systemic lupus erythematosus The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection IP-10 and type 1 diabetes: a question of time and location. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis Abnormal T cell signal transduction in systemic lupus erythematosus Enhanced expression of interferon-inducible protein 10 associated with Th1 profiles of chemokine receptor in autoimmune pulmonary inflammation of MRL/lpr mice Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus Do lupus disease activity measures detect clinically important change? Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity
author name string	wds:Q58620300-002270F2-0741-4BB9-81ED-3C1420B74F51 wds:Q58620300-24B6DB70-3931-4442-A6EE-3274D362DF6D wds:Q58620300-28CA52C5-4B36-4AFB-B49F-FE95C92DEE96 wds:Q58620300-431A3AD6-454A-451A-AF55-ACE81C8523A0 wds:Q58620300-8F6F1802-4159-4237-BE44-D2F97E7909B7 wds:Q58620300-A2813890-8581-4183-B21F-267465B37CE7 wds:Q58620300-A5D4BB27-F3A1-4FD5-85BA-F75CBB31713D wds:Q58620300-BAE6DED5-61DE-4048-94B9-A145704C8719 wds:Q58620300-C021543D-FE79-45F7-8958-2789D11A58B0 wds:Q58620300-D100676C-A378-447D-9244-4FA5D4C4458E wds:Q58620300-F316B495-CFB4-4DE4-8881-6075E4A959A9 wds:Q58620300-F7782972-6380-475A-A551-666FF623BF4F
author name string	E T Koh Y K Cheng C L Teh H H Chng K P Leong T C Lau H S Howe B Y H Thong W G Law T Y Lian K O Kong A W Tan
rdfs:label	Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus (en) Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus (nl)
skos:prefLabel	Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus (en) Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software